Literature DB >> 19935643

Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers.

Matthew M Yeh1, Hubert Darius-J Daniel, Michael Torbenson.   

Abstract

Chronic hepatitis C viral infection can lead to cirrhosis and hepatocellular carcinoma. It is generally believed that hepatitis C infection is not oncogeneic per se, but that the presence of cirrhosis determines the increased risk for hepatocellular carcinoma. However, a search of surgical pathology files from two large tertiary care centers for the years 2001-2008 identified a total of 18 hepatocellular carcinomas in non-cirrhotic livers with chronic hepatitis C infection. In six cases the background livers showed bridging fibrosis, while the remainder showed lower stages of fibrosis. Cases were negative for clinical and serological evidence of hepatitis B co-infection, and occult hepatitis B test was negative by PCR of formalin-fixed, paraffin embedded tissues. The tumors were also negative for TP53, exon 7, codon 249 mutations, a characteristic mutation strongly linked to aflatoxin exposure. The hepatocellular carcinomas had typical histology with no enrichment for unusual growth patterns or histological features. Among all resected hepatocellular carcinomas in non-cirrhotic livers over this time period, the prevalence of 16% with HCV infection was significantly greater than that expected by chance. In conclusion, these results demonstrate that hepatocellular carcinomas can arise in livers chronically infected with hepatitis C but without cirrhosis. These findings raise the possibility that in some cases hepatitis C infection and inflammation can be directly oncogeneic. It is also possible that established cirrhosis may have regressed in some cases. Regardless of the mechanism, these findings highlight an important and previously under-recognized risk for hepatocellular carcinoma in HCV-infected individuals who do not have cirrhosis.

Entities:  

Mesh:

Year:  2009        PMID: 19935643      PMCID: PMC3037012          DOI: 10.1038/modpathol.2009.174

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  29 in total

Review 1.  Hepatitis B viruses and hepatocellular carcinoma.

Authors:  M A Buendia
Journal:  Adv Cancer Res       Date:  1992       Impact factor: 6.242

2.  Macroregenerative nodule of the liver. A clinicopathologic study of 345 autopsy cases of chronic liver disease.

Authors:  K Furuya; M Nakamura; Y Yamamoto; K Togei; H Otsuka
Journal:  Cancer       Date:  1988-01-01       Impact factor: 6.860

3.  Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.

Authors:  H C Hsu; Y M Jeng; T L Mao; J S Chu; P L Lai; S Y Peng
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

4.  Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status.

Authors:  Adrian M Di Bisceglie; Andre C Lyra; Myron Schwartz; Rajender K Reddy; Paul Martin; Gregory Gores; Anna S F Lok; Khozema B Hussain; Robert Gish; David H Van Thiel; Zobair Younossi; Myron Tong; Tarek Hassanein; Luis Balart; Jacquelyn Fleckenstein; Stephen Flamm; Andres Blei; Alex S Befeler
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

5.  Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death.

Authors:  F Degos; C Christidis; N Ganne-Carrie; J P Farmachidi; C Degott; C Guettier; J C Trinchet; M Beaugrand; S Chevret
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

6.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

7.  Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C.

Authors:  T-M Scherzer; K R Reddy; F Wrba; H Hofer; K Staufer; P Steindl-Munda; A Gangl; P Ferenci
Journal:  J Viral Hepat       Date:  2008-07-10       Impact factor: 3.728

8.  Adenomatous hyperplasia in the vicinity of small hepatocellular carcinoma.

Authors:  A Eguchi; O Nakashima; S Okudaira; S Sugihara; M Kojiro
Journal:  Hepatology       Date:  1992-05       Impact factor: 17.425

9.  Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma.

Authors:  T Takayama; M Makuuchi; S Hirohashi; M Sakamoto; N Okazaki; K Takayasu; T Kosuge; Y Motoo; S Yamazaki; H Hasegawa
Journal:  Lancet       Date:  1990-11-10       Impact factor: 79.321

Review 10.  Occult hepatitis B.

Authors:  Michael Torbenson; David L Thomas
Journal:  Lancet Infect Dis       Date:  2002-08       Impact factor: 25.071

View more
  18 in total

1.  Incidence and risk factors for surveillance failure in patients with regular hepatocellular carcinoma surveillance.

Authors:  Dong Hyun Sinn; Jieun Yi; Moon Seok Choi; Dongil Choi; Geum-Youn Gwak; Yong-Han Paik; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  Hepatol Int       Date:  2013-07-27       Impact factor: 6.047

2.  Novel approach for quantification of hepatitis C virus in liver cirrhosis using real-time reverse transcriptase PCR.

Authors:  Kewal Krishan Maudar; Puneet Gandhi; Pradyumna Kumar Mishra; Subodh Varshney; Ramprakash Punde; Arpit Bhargav
Journal:  J Gastrointest Surg       Date:  2011-11-03       Impact factor: 3.452

Review 3.  Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer.

Authors:  D R McGivern; S M Lemon
Journal:  Oncogene       Date:  2011-01-24       Impact factor: 9.867

4.  Cost-effectiveness and population outcomes of general population screening for hepatitis C.

Authors:  Phillip O Coffin; John D Scott; Matthew R Golden; Sean D Sullivan
Journal:  Clin Infect Dis       Date:  2012-03-12       Impact factor: 9.079

5.  Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease.

Authors:  Sahil Mittal; Hashem B El-Serag; Yvonne H Sada; Fasiha Kanwal; Zhigang Duan; Sarah Temple; Sarah B May; Jennifer R Kramer; Peter A Richardson; Jessica A Davila
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-18       Impact factor: 11.382

6.  Hepatitis C virus-associated primary hepatocellular carcinoma in non-cirrhotic patients.

Authors:  Mazen Albeldawi; Mohamed Soliman; Rocio Lopez; Nizar N Zein
Journal:  Dig Dis Sci       Date:  2012-06-14       Impact factor: 3.199

Review 7.  Allostasis in nonalcoholic fatty liver disease: implications for risk assessment.

Authors:  György Baffy
Journal:  Dig Dis Sci       Date:  2012-08-11       Impact factor: 3.199

Review 8.  Genomics of Viral Hepatitis-Associated Liver Tumors.

Authors:  Camille Péneau; Jessica Zucman-Rossi; Jean-Charles Nault
Journal:  J Clin Med       Date:  2021-04-22       Impact factor: 4.241

9.  Response to combination therapy of HCV 3a infected Pakistani patients and the role of NS5A protein.

Authors:  Ijaz Ali; Sanaullah Khan; Sobia Attaullah; Shahid Niaz Khan; Jabbar Khan; Sami Siraj; Aqib Iqbal; Zahoor A Swati; Muhammad Idrees
Journal:  Virol J       Date:  2011-05-25       Impact factor: 4.099

10.  Hepatocellular Carcinoma in a non-Cirrhotic Liver of a HCV-Positive Woman with Sustained Viral Response.

Authors:  L Nosotti; T D'Arca; M Marignani; G Balducci
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-10-26       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.